References
- Dunstan DW, Zimmet PZ, Welborn TA, et al. The rising prevalence of diabetes and impaired glucose tolerance. The Australian Diabetes, Obesity and Lifestyle Study. Diabetes Care 2002; 25: 829–34.
- The Expert Committee on Non-communicable Disease. Non-communicable Disease in Nigeria. Final Report of a National Survey; 1997.
- Young TK, Mustard CA. Undiagnosed diabetes: does it matter? CMAJ 2001; 164(1): 24–8.
- Harris MI, Flegal KM, Cowie CC, et al. Prevalence of diabetes, impaired fasting glucose, impaired glucose tolerance in US adults. Diabetes Care 1998; 21: 518–24.
- Ajala MO, Oladipo OO, Fasanmade O, Adewole TA. Laboratory assessment of three glucometers. Afr J Med Sci 2003; 32: 279–82.
- Amoah AG. Undiagnosed diabetes and impaired glucose regulation in adult Ghanaians using the ADA and WHO diagnostic criteria. Acta Diabetol 2002; 39(1): 7–13.
- Finch CF, Zimmet PZ, Alberti KGMM. Determining diabetes prevalence: a rational basis for the use of fasting plasma glucose concentration. Diabetic Medicine 19; 7: 603–10.
- The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1997; 20: 1183–97.
- World Health Organization Consultation on Obesity. Geneva; 1997.
- Epi Info 2002 Database and statistics software for public health professionals. Centre for Disease Control and Prevention: Atlanta; 2002.
- King H, Rewers M. Global estimates for the prevalence of diabetes mellitus and impaired glucose tolerance in adults. WHO Ad Hoc Reporting Group. Diabetes Care 1993; 16: 157–77.
- Owoaje EE, Rotimi CN, Kaufman JS, Tracy J, Cooper RS. Prevalence of adult diabetes in Ibadan, Nigeria. East Afr Med J 1997; 74(5): 299–302.
- Olatunbosun ST, Bella AF. Relationship between height, glucose intolerance, and hypertension in an urban African black adult population: a case for the “thrifty phenotype” hypothesis? J Natl Med Assoc 2000; 92(6): 265–8.
- Amos AF, McCarty DJ, Zimmet P. The rising global burden of diabetes and its complications: estimates and projection to the year 2010. Diabetic Medicine 1997; 14(Suppl 5): S1–85.
- Unwin N, Sobugwi E, Alberti KGMM. Type 2 diabetes: the challenge of preventing a global epidemic. Diabetes International 2001; 11: 4–8.
- World Health Organization. Prevention of diabetes mellitus. Report of a WHO Study Group. WHO Technical Report Series 844. Geneva: WHO; 1994.
- Amoah AG, Owusu SK, Adjei S. Diabetes in Ghana: a community based prevalence study in Greater Accra. Diabetes Res Clin Pract 2002; 56(3): 197–205.
- Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman M, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 1993; 16: 601–7.
- Bitzen PO, Schersten B. Assessment of laboratory methods for detection of unsuspected diabetes in primary health care. Scand J Prim Health Care 1986; 4(2): 85–95.
- Murphy NJ, Boyko EJ, Schraer CD, Bulkow LR, Lanier AP. Use of a reflectance photometer as a diabetes mellitus screening tool under field conditions. Arctic Med Res 1993; 52(4): 170–4.
- Elbagir MN, Eltom MA, Elmahadi EM, Kadam IM, Berne C. A population-based study of the prevalence of diabetes and impaired glucose tolerance in adults in Northern Sudan. Diabetes Care 1996; 19: 1126–8.
- Greaves CJ, Stead JW, Hattersley AT, Ewings P, Brown P, Evans PH. A simple pragmatic system for detecting new cases of type 2 diabetes and impaired fasting glycemia in primary care. Family Practice 2004; 21(1): 57–62.
- Olatunbosun ST, Ojo PO, Fineberg NS, Bella AF. Prevalence of diabetes mellitus and impaired glucose tolerance in a group of urban adults in Nigeria. J Natl Med Assoc 1998; 90: 293–301.
- Edelman D, Edwards LJ, Olsen MK, et al. Screening for diabetes in an outpatient clinic population. J Gen Intern Med 2002; 17(1): 23–8.
- King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025. Prevalence, numerical estimates and projections. Diabetes Care 1998; 21: 1414–31.
- Mbanya JC, Ngogang J, Salah JN, Minkoulou E, Balkau B. Prevalence of NIDDM and impaired glucose tolerance in a rural and an urban population in Cameroon. Diabetologia 1997; 40(7): 824–9.
- Rimm EB, Chan J, Stampfer MJ, et al. Prospective study of cigarette smoking, alcohol use and the risk of diabetes in men. BMJ 1995; 310: 555–9.
- Wannamethee SG, Shaper AG, Alberti KGMM. Alcohol consumption and the risk of type II diabetes. Journal of Epidemiology and Community Health 2002; 56: 542–8.
- Wei M, Kampert JB, Gibbons LW. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care 2000; 23(1): 18–22.
- Nakanishi N, Suzuki K, Tatara K. Alcohol consumption and risk for development of impaired fasting glucose in middle-aged Japanese men. Diabetes Care 2003; 26: 48–54.
- Mbanya JC, Cruickshank JK, Forrester T, et al. Standardized comparison of glucose intolerance in west African-origin populations of rural and urban Cameroon, Jamaica, and Caribbean migrants to Britain. Diabetes Care 1999; 22(3): 434–40.
- Hillier TA, Pedula KL. Characteristics of an adult population with newly diagnosed type 2 diabetes. The relation of obesity and age of onset. Diabetes Care 2001; 24: 1522–7.
- Elmahdi EM, Kaballo AM, Mukhtar EA. Features of non-insulin dependent diabetes mellitus (NIDDM) in the Sudan. Diabetes Res Clin Pract 1991; 11(1): 59–63.
- Reenders K, De Nobel E, Van den Hoogen HJ, Rutten GE, Van Weel C. Diabetes and its long term complications in general practice: a survey in a well-defined population. Fam Pract 1993; 10(2): 169–72.
- Elbagir MN, Eltom MA, Mahadi EO, Berne C. Pattern of long-term complications in Sudanese insulin-treated diabetic patients. Diabetes Res Clin Pract 1995; 30(1): 59–67.
- Mimi O, Teng CL, Chia YC. The prevalence of diabetic peripheral neuropathy in an outpatient setting. Med J Malaysia 2003; 58(4): 533–8.
- Wanjobi FW, Otieno FCF, Ogola EN, Amayo EO. Nephropathy in patients with recently diagnosed type 2 diabetes mellitus in black Africans. East African Medical Journal 2002; 79: 399–404.
- Harris MI, Klein R, Welbourn TA, et al. Onset of NIDDM occurs at least 4–7 yr before clinical diagnosis. Diabetes Care 1992; 15: 815–9.
- Agaba IE, Anteyi EA, Puepet FH, Omudu PA, Idoko JA. Hypertension in type II diabetes mellitus in Jos University Teaching Hospital, Jos, Nigeria. Highland Medical Research Journal 2002; 1: 22–4.